Literature DB >> 26493631

Caffeine stimulates locomotor activity in the mammalian spinal cord via adenosine A1 receptor-dopamine D1 receptor interaction and PKA-dependent mechanisms.

JeanMarie Acevedo1, Alexandra Santana-Almansa1, Nikol Matos-Vergara1, Luis René Marrero-Cordero1, Ernesto Cabezas-Bou1, Manuel Díaz-Ríos2.   

Abstract

Caffeine is a potent psychostimulant that can have significant and widely variable effects on the activity of multiple neuronal pathways. The most pronounced caffeine-induced behavioral effect seen in rodents is to increase locomotor activity which has been linked to a dose-dependent inhibition of A1 and A(2A) receptors. The effects of caffeine at the level of the lumbar spinal central pattern generator (CPG) network for hindlimb locomotion are lacking. We assessed the effects of caffeine to the locomotor function of the spinal CPG network via extracellular ventral root recordings using the isolated neonatal mouse spinal cord preparation. Addition of caffeine and of an A1 receptor antagonist significantly decreased the cycle period accelerating the ongoing locomotor rhythm, while decreasing burst duration reversibly in most preparations suggesting the role of A1 receptors as the primary target of caffeine. Caffeine and an A1 receptor antagonist failed to stimulate ongoing locomotor activity in the absence of dopamine or in the presence of a D1 receptor antagonist supporting A1/D1 receptor-dependent mechanism of action. The use of caffeine or an A1 receptor blocker failed to stimulate an ongoing locomotor rhythm in the presence of a blocker of the cAMP-dependent protein kinase (PKA) supporting the need of this intracellular pathway for the modulatory effects of caffeine to occur. These results support a stimulant effect of caffeine on the lumbar spinal network controlling hindlimb locomotion through the inhibition of A1 receptors and subsequent activation of D1 receptors via a PKA-dependent intracellular mechanism.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenosine; Caffeine; Dopamine; Locomotion; Mouse; Spinal cord

Mesh:

Substances:

Year:  2015        PMID: 26493631      PMCID: PMC4855515          DOI: 10.1016/j.neuropharm.2015.10.020

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  98 in total

Review 1.  Mechanisms by which dopamine receptors may influence synaptic plasticity.

Authors:  Marina E Wolf; Simona Mangiavacchi; Xiu Sun
Journal:  Ann N Y Acad Sci       Date:  2003-11       Impact factor: 5.691

Review 2.  Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons.

Authors:  Luigi F Agnati; Sergi Ferré; Carme Lluis; Rafael Franco; Kjell Fuxe
Journal:  Pharmacol Rev       Date:  2003-07-17       Impact factor: 25.468

3.  A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release.

Authors:  J Harvey; M G Lacey
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

4.  Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study.

Authors:  P Svenningsson; H Hall; G Sedvall; B B Fredholm
Journal:  Synapse       Date:  1997-12       Impact factor: 2.562

Review 5.  Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia.

Authors:  S Ferré; B B Fredholm; M Morelli; P Popoli; K Fuxe
Journal:  Trends Neurosci       Date:  1997-10       Impact factor: 13.837

6.  Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression.

Authors:  C Le Moine; P Svenningsson; B B Fredholm; B Bloch
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

7.  D1 receptor activation enhances evoked discharge in neostriatal medium spiny neurons by modulating an L-type Ca2+ conductance.

Authors:  S Hernández-López; J Bargas; D J Surmeier; A Reyes; E Galarraga
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

8.  Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens.

Authors:  P Svenningsson; G G Nomikos; E Ongini; B B Fredholm
Journal:  Neuroscience       Date:  1997-08       Impact factor: 3.590

9.  The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses.

Authors:  T Blank; I Nijholt; U Teichert; H Kügler; H Behrsing; A Fienberg; P Greengard; J Spiess
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

Review 10.  Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilities.

Authors:  Bertil B Fredholm; Per Svenningsson
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

View more
  11 in total

Review 1.  Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders.

Authors:  Sergi Ferré
Journal:  Psychopharmacology (Berl)       Date:  2016-01-20       Impact factor: 4.530

2.  Adenosine A1-Dopamine D1 Receptor Heteromers Control the Excitability of the Spinal Motoneuron.

Authors:  Marla Rivera-Oliver; Estefanía Moreno; Yocasta Álvarez-Bagnarol; Christian Ayala-Santiago; Nicole Cruz-Reyes; Gian Carlo Molina-Castro; Stefan Clemens; Enric I Canela; Sergi Ferré; Vicent Casadó; Manuel Díaz-Ríos
Journal:  Mol Neurobiol       Date:  2018-05-24       Impact factor: 5.590

Review 3.  Gliotransmission and adenosinergic modulation: insights from mammalian spinal motor networks.

Authors:  David Acton; Gareth B Miles
Journal:  J Neurophysiol       Date:  2017-09-27       Impact factor: 2.714

4.  Pivotal Role of Adenosine Neurotransmission in Restless Legs Syndrome.

Authors:  Sergi Ferré; César Quiroz; Xavier Guitart; William Rea; Arta Seyedian; Estefanía Moreno; Verònica Casadó-Anguera; Manuel Díaz-Ríos; Vicent Casadó; Stefan Clemens; Richard P Allen; Christopher J Earley; Diego García-Borreguero
Journal:  Front Neurosci       Date:  2018-01-08       Impact factor: 4.677

5.  Modulation of spinal motor networks by astrocyte-derived adenosine is dependent on D1-like dopamine receptor signaling.

Authors:  David Acton; Matthew J Broadhead; Gareth B Miles
Journal:  J Neurophysiol       Date:  2018-05-23       Impact factor: 2.714

6.  Effect of chronic administration and withdrawal of caffeine on motor function, cognitive functions, anxiety, and the social behavior of BLC57 mice.

Authors:  Sadiq Mahdi; Sayed Almosawi; Hasan Baksh; Abdulrahman Qareeballa; Bano Alsaleh; Faisal Falamarzi; Malak Alrabaani; Ali Alkalbani; Amer Kamal
Journal:  Int J Health Sci (Qassim)       Date:  2019 Mar-Apr

7.  Caffeine increases performance and leads to a cardioprotective effect during intense exercise in cyclists.

Authors:  Felipe Sampaio-Jorge; Anderson Pontes Morales; Rafael Pereira; Thiago Barth; Beatriz Gonçalves Ribeiro
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

8.  Deletion of Trace Amine-Associated Receptor 1 Attenuates Behavioral Responses to Caffeine.

Authors:  Michael D Schwartz; Jeremiah B Palmerston; Diana L Lee; Marius C Hoener; Thomas S Kilduff
Journal:  Front Pharmacol       Date:  2018-02-02       Impact factor: 5.810

9.  Energy drink: the consumption prevalence, and awareness of its potential health implications among commercial drivers in the Ho municipality of Ghana.

Authors:  Emmanuella Yayra Saku; Peter Nuro-Ameyaw; Priscilla Cecilia Amenya; Fidelis Mawunyo Kpodo; Paul Esua-Amoafo; Nii Korley Kortei
Journal:  BMC Public Health       Date:  2020-08-27       Impact factor: 3.295

10.  A dynamic role for dopamine receptors in the control of mammalian spinal networks.

Authors:  Simon A Sharples; Nicole E Burma; Joanna Borowska-Fielding; Charlie H T Kwok; Shane E A Eaton; Glen B Baker; Celine Jean-Xavier; Ying Zhang; Tuan Trang; Patrick J Whelan
Journal:  Sci Rep       Date:  2020-10-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.